qPCR and dPCR Instrumentation Market Is Expected to 1630 Million US$ During 2013-2025

This report studies the qPCR and dPCR Instrumentation market size (value and volume) by players, regions, product types and end industries, history data 2013-2017 and forecast data 2018-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Real-time PCR or quantitative PCR is a well-established technology that has become the tool of choice for the rapid, sensitive quantification of nucleic acid in various biological samples. qPCR measures the accumulation of DNA during a PCR reaction. The increase in quantity of DNA at each cycle is measured by the change in intensity of a fluorescent signal. Comparison to a reference sample determines the number of original copies of template DNA in the reaction.

Digital PCR is a highly precise approach to sensitive nucleic acid detection and quantification. Each sample is partitioned into thousands of individual reactions (droplets for Droplet Digital™ PCR technology). Each partition is analyzed after end-point PCR cycling for the presence or absence of a fluorescent signal, and the absolute number of molecules present in the sample is calculated. dPCR does not require a standard curve for quantification.

Both quantitative PCR (qPCR) and digital PCR (dPCR) provide sensitive and specific detection, and precise quantification of nucleic acids. Both technologies have similarities, but they have differences that make one or the other the more adapted choice for specific applications.

On the basis of technology, the dPCR and qPCR market is categorized into digital PCR (dPCR) and quantitative PCR (qPCR/real-time PCR). The qPCR technology segment is expected to account for the larger share of the global dPCR and qPCR market in 2017; whereas, the dPCR segment is expected to grow at the highest CAGR during the forecast period. Factors such as ongoing technological developments in dPCR, continued expansion in distribution networks of emerging dPCR product manufacturers in global markets, and growing private funding to develop and commercialize innovative dPCR instruments are contributing to the growth of the dPCR technology segment.

On the basis of application, the dPCR and qPCR market is categorized into clinical applications, research applications, and others. The clinical applications segment is further divided into pathogen testing, oncology testing, blood screening, and other clinical applications. The clinical applications segment is expected to grow at the highest CAGR during the forecast period owing to the technological benefits offered by dPCR over qPCR and traditional PCR, growing adoption of dPCR among hospitals and diagnostic centers, increasing global burden for infectious diseases and cancer, and expansion in distribution networks of emerging dPCR product manufacturers.

Geographically, North America holds the largest market share, with about 48.68% production share and 40.77% consumption market share in 2017, followed by Europe. The strong position of North America in this market can be attributed to factors such as increase in public and private funding and growing number of research grants to support gene-based research (such as qPCR and dPCR).

Asia-Pacific is projected to be the fastest-growing region in the qPCR and dPCR market owing to increasing focus of global life sciences market players on this region, burgeoning efforts to increase awareness related to gene-based disease diagnosis and treatment, growing public and private support to develop novel qPCR and dPCR technologies. Due to the significant growth opportunities offered by emerging countries, a number of players operating in the market are focusing on expanding their product distribution networks across emerging countries.

The global qPCR and dPCR Instrumentation market was 930 million US$ in 2017 and is expected to 1630 million US$ by the end of 2025, growing at a CAGR of 7.3% between 2018 and 2025. Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of qPCR and dPCR Instrumentation in these regions, from 2013 to 2025, covering

North America (United States, Canada and Mexico).Europe (Germany, UK, France, Italy, Russia and Turkey etc.).Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam).South America (Brazil etc.).Middle East and Africa (Egypt and GCC Countries)

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in this market include

Thermo Fisher

Roche

QIAGEN

Bio-rad

Agilent

Bioer

Biosynex

Esco

Analytics Jena

Techne

Fluidigm

RainDance Technologies

By the product type, the market is primarily split into

dPCR

qPCR

By the end users/application, this report covers the following segments

Clinical Use

Research Use

Other

Request Sample Copy of Report@ https://www.qyresearch.com/sample-form/form/500114/global-qpcr-and-dpcr-instrumentation-market

Market size split by Region

•North America
•Asia-Pacific
•Europe
•Central & South America
•Middle East & Africa

Benefits of Purchasing QY Research Report

• Analyst Support: Get you query resolved from our expert analysts before and after purchasing the report
•Customer's Satisfaction: Our expert team will assist with all your research needs and customize the report
• Inimitable Expertise: Analysts will provide deep insights about the reports
• Assured Quality: We focus on the quality and accuracy of the report

Request to Buy Full Report@ https://www.qyresearch.com/settlement/pre/e7dd24851876320916f2ef6840203fd9,0,1

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

QY Research, INC.
17890 Castleton,
Suite 218,
City of industry, CA – 91748
USA: +1 626 295 2442
Email: enquiry@qyresearch.com
Web: http://www.qyresearch.com

This release was published on openPR.